Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ketchem Biotherapeutics Consulting provides expert scientific advising and strategic guidance for biotherapeutic discovery and design. The firm specializes in computational structural biology, antibody engineering/humanization/optimization, molecular modeling/design, biologic software platforms direction, and training for biopharma clients. Its president—Randal R. Ketchem—is an inventor of evolocumab (for hyperlipidemia), led development of AI-driven antibody discovery technologies at Just/Evotec Biologics/Amgen/Immunex/Scripps Research Institute.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ketchem Biotherapeutics Consulting.